ExThera Medical Corp.
Hemofiltration to treat bloodstream infections
This article was originally published in Start Up
Executive Summary
In an effort to dramatically reduce the complications associated with bloodstream infections and their progression to sepsis, ExThera Medical Corp. has developed a whole blood affinity therapy device for use in an extracorporeal circuit. Similar in concept to a filter for a swimming pool, the compact Seraph Microbind Affinity Blood Filter has the unique ability to safely remove a wide range of pathogens and toxins from the blood by employing immobilized heparin.
You may also be interested in...
Investors Go Beserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.